产品说明
应用
Procarbazine, an antineoplastic alkylating agent, may be used to study its pharmacokinetics, metabolism, safety, efficacy and methods of delivery as an anticancer agent. It may be used to study new combination of anticancer drugs.
Procarbazine hydrochloride has been used to study its physicochemical property.
包装
10, 50 mg in glass bottle
生化/生理作用
Procarbazine is an antineoplastic alkylating agent widely used in cancer chemotherapy in combination with other compounds. It has multiple mechanisms of action. Procarbazine inhibits protein, RNA and DNA synthesis in addition to being an alkylating agent.
Procarbazine is metabolized to azoprocarbazine either by cytochrome P450 enzyme and monoamine oxidase in an NADPH (nicotinamide adenine diphosphate) dependent or independent manner. It is considered neurotoxic. Procarbazine is used in combination with therapy for treating Hodgkin′s disease.
基本信息
| 经验(实验)分子式 | C12H19N3O·HCl |
| 分子量 | 257.76 |
| EC 号 | 206-678-6 |
| MDL编号 | MFCD00072082 |
| PubChem化学物质编号 | 329825106 |
| NACRES | NA.77 |
产品性质
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | white to tan |
| 溶解性 | DMSO: ≥18 mg/mL |
| 储存温度 | 2-8℃ |
| SMILES string | Cl.CNNCc1ccc(cc1)C(=O)NC(C)C |
| InChI | 1S/C12H19N3O.ClH/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3;/h4-7,9,13-14H,8H2,1-3H3,(H,15,16);1H |
| InChI key | DERJYEZSLHIUKF-UHFFFAOYSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H302 - H341 - H350 - H360 |
| 预防措施声明 | P201 - P301 + P312 + P330 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Carc. 1B - Muta. 2 - Repr. 1A |
| 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
